NCT02046928

Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: TERMINATED

Phase: PHASE2

Sponsor: Ångstrom Pharmaceuticals

Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL, SLL

Signal summary

Status signal: Registry Stop Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: None

Stopped reason

Slow enrollment